Is low and slow the way to go? Metronomic therapy in the treatment of pediatric brain tumors

By Wolf David S   Cohen Kenneth J  

CNS Oncology, Vol. 2, Iss. 3, 2013-05 ,pp. : 211-213

Future Medicine

Access to resources Recommend Favorite

Chemoinformatics in Multi-target Drug Discovery for Anti-cancer Therapy: In Silico Design of Potent and Versatile Anti-brain Tumor Agents

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 6, 2012-07 ,pp. : 678-685

Bentham Science Publishers

Access to resources Recommend Favorite

A tale of two approaches: complementary mechanisms of cytotoxic and targeted therapy resistance may inform next-generation cancer treatments

By Masui Kenta  

Carcinogenesis, Vol. 34, Iss. 4, 2013-04 ,pp. : 725-738

Oxford University Press

Access to resources Recommend Favorite

Telomerase Inhibitors as Anticancer Therapy

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 2, Iss. 5, 2002-01 ,pp. : 567-575

Bentham Science Publishers

Access to resources Recommend Favorite

Glucuronides in Anti-Cancer Therapy

By  

Current Medicinal Chemistry - Anti-Cancer Agents, Vol. 3, Iss. 2, 2003-03 ,pp. : 139-150

Bentham Science Publishers

Access to resources Recommend Favorite